カテゴリ： MarketLine, 企業調査, 日本

Taisho Pharmaceutical Holdings Co Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4459
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：35
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Taisho Pharmaceutical Holdings Co Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Taisho Pharmaceutical Holdings Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Taisho Pharmaceutical Holdings Co Ltd (Taisho Pharmaceutical) develops, manufactures and markets self-medication drugs and prescription pharmaceuticals. Its self-medication products comprise over-the-counter (OTC) products, quasi-drugs and health food products. The company’s prescription pharmaceuticals portfolio includes ethical drugs in the fields of infectious diseases, orthopedic disorders, central nervous system (CNS) diseases and metabolic diseases. Taisho Pharmaceutical also has various products in pipeline such as TS-091 for central disorders of hypersomnolence; TS-141 for childhood attention-deficit/hyperactivity disorder; TS-121 for depression; and TS-133 for alopecia, among others. It distributes products through its subsidiaries located in the Philippines, Indonesia, Malaysia, Thailand, Vietnam, China, Singapore, Taiwan, and the US. Taisho Pharmaceutical is headquartered in Toshima-ku, Tokyo, Japan.

Scope

- Detailed information on Taisho Pharmaceutical Holdings Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Taisho Pharmaceutical Holdings Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Taisho Pharmaceutical Holdings Co Ltd including a breakdown and examination of key business segments
- Intelligence on Taisho Pharmaceutical Holdings Co Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Taisho Pharmaceutical Holdings Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Taisho Pharmaceutical Holdings Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Taisho Pharmaceutical Holdings Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Taisho Pharmaceutical Holdings Co Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Taisho Pharmaceutical Holdings Co Ltd: Company Overview 9
Taisho Pharmaceutical Holdings Co Ltd: Overview and Key Facts 9
Taisho Pharmaceutical Holdings Co Ltd: Overview 9
Taisho Pharmaceutical Holdings Co Ltd: Key Facts 9
Taisho Pharmaceutical Holdings Co Ltd: Key Employees 10
Taisho Pharmaceutical Holdings Co Ltd: Key Employee Biographies 11
Taisho Pharmaceutical Holdings Co Ltd: Major Products and Services 12
Taisho Pharmaceutical Holdings Co Ltd: Company History 13
Taisho Pharmaceutical Holdings Co Ltd: Management Statement 15
Taisho Pharmaceutical Holdings Co Ltd: Locations and Subsidiaries 16
Taisho Pharmaceutical Holdings Co Ltd: Key Competitors 18
Taisho Pharmaceutical Holdings Co Ltd: Company Analysis 19
Taisho Pharmaceutical Holdings Co Ltd: Business Description 19
Taisho Pharmaceutical Holdings Co Ltd: SWOT Analysis 20
Taisho Pharmaceutical Holdings Co Ltd: SWOT Overview 20
Taisho Pharmaceutical Holdings Co Ltd: Strengths 20
Taisho Pharmaceutical Holdings Co Ltd: Weaknesses 21
Taisho Pharmaceutical Holdings Co Ltd: Opportunities 21
Taisho Pharmaceutical Holdings Co Ltd: Threats 22
Taisho Pharmaceutical Holdings Co Ltd: Corporate Financial Deals Activity 23
Taisho Pharmaceutical Holdings Co Ltd: Financial Deals Overview 23
Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners 25
Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2014 – 2018YTD* 26
Taisho Pharmaceutical Holdings Co Ltd: Mergers and Acquisitions 27
Taisho Pharmaceutical Holdings Co Ltd: Partnership 28
Taisho Pharmaceutical Holdings Co Ltd: Divestments 29
Taisho Pharmaceutical Holdings Co Ltd: Recent Developments 30
Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary 30
Taisho Pharmaceutical Holdings Co Ltd: Financial Performance 30
Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events 31
Taisho Pharmaceutical Holdings Co Ltd: Strategy and Operations 32
Appendix 33
Contact Us 33
Methodology 33
About MarketLine 34

List of Tables
Table 1: Taisho Pharmaceutical Holdings Co Ltd: Key Facts
Table 2: Taisho Pharmaceutical Holdings Co Ltd: Key Employees
Table 3: Taisho Pharmaceutical Holdings Co Ltd: Locations and Subsidiaries
Table 4: Taisho Pharmaceutical Holdings Co Ltd: Key Competitors
Table 5: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (TTM*)
Table 7: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Taisho Pharmaceutical Holdings Co Ltd: M&A Average Deal Size - Value (US$m)
Table 9: Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners
Table 10: Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2014 - 2018YTD*
Table 11: Taisho Pharmaceutical Holdings Co Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Taisho Pharmaceutical Holdings Co Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Taisho Pharmaceutical Holdings Co Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Taisho Pharmaceutical Holdings Co Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: Taisho Pharmaceutical Holdings Co Ltd: Divestments by Geography (2014 - YTD*2018)
Table 17: Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary
Table 18: Taisho Pharmaceutical Holdings Co Ltd: Financial Performance
Table 19: Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events
Table 20: Taisho Pharmaceutical Holdings Co Ltd: Strategy and Operations

List of Figures
Figure 1: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (TTM*)
Figure 3: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Taisho Pharmaceutical Holdings Co Ltd: M&A Average Deal Size - Value (US$m)
Figure 5: Taisho Pharmaceutical Holdings Co Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Taisho Pharmaceutical Holdings Co Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Taisho Pharmaceutical Holdings Co Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Taisho Pharmaceutical Holdings Co Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Taisho Pharmaceutical Holdings Co Ltd: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Taisho Pharmaceutical Holdings Co Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • BeneChill Inc-医療機器分野：企業M&A・提携分析
    Summary BeneChill Inc (BeneChill) is a medical device company that develops, manufactures and sells novel rapid cooling technologies. The company offers products which include therapeutic hypothermia and intranasal cooling systems. Its intranasal cooling systems offer cooling that can be initiated b …
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC), a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketing and licensing the inventions, products, and technologies developed by the university's faculty, …
  • NTPC Ltd (NTPC)：石油・ガス：M&Aディール及び事業提携情報
    Summary NTPC Ltd (NTPC) is a Public sector undertaking energy conglomerate. It has presence in the entire value chain of the power generation business. The company produces electricity and sells that to state power utilities on wholesale basis. NTPC generates power using coal, gas, liquid fuel and h …
  • Global Insurance Management Limited：企業の戦略・SWOT・財務分析
    Global Insurance Management Limited - Strategy, SWOT and Corporate Finance Report Summary Global Insurance Management Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • SNGN Romgaz SA (SNG)：企業の財務・戦略的SWOT分析
    Summary SNGN Romgaz SA (Romgaz) is an oil and gas company which explores produces and supplies natural gas. The company's activities include exploration of petroleum onshore and offshore, natural gas production, electric power production, trading and technological transport. Romgaz through its well …
  • Relation Insurance Services, Inc：企業の戦略・SWOT・財務分析
    Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report Summary Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Centre for Drug Design and Discovery-製薬・医療分野：企業M&A・提携分析
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution provides services such as silico molecule design, modelling and screening, medicinal chemistry, intellectual property rights support, business development, …
  • HCL Technologies Ltd (HCLTECH)：企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Newfoundland and Labrador Hydro：企業の戦略的SWOT分析
    Newfoundland and Labrador Hydro - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Advanced Marker Discovery SL-医療機器分野：企業M&A・提携分析
    Summary Advanced Marker Discovery SL (Amadix) is a developer and discoverer of cancer diagnostic products. The company offers test products and diagnostic tools for lung cancer, colon cancer and prostate cancer. It provides diagnostic tools that support the physician’s decisions about patient manage …
  • Cosan S.A. Industria e Comercio (CSAN3)：企業の財務・戦略的SWOT分析
    Cosan S.A. Industria e Comercio (CSAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • United Orthopedic Corp (4129)：医療機器：M&Aディール及び事業提携情報
    Summary United Orthopedic Corp (UOC) is a medical device company that designs, manufactures and distributes orthopedic implants and instrument sets. The company provides product categories such as knee replacement systems, hip replacement systems, and oncology products, among others. It offers hip r …
  • Huesker Synthetic Gmbh
    Huesker Synthetic Gmbh - Strategy, SWOT and Corporate Finance Report Summary Huesker Synthetic Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Xinjiang Goldwind Science & Technology Co Ltd (002202)：企業の財務・戦略的SWOT分析
    Xinjiang Goldwind Science & Technology Co Ltd (002202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Asahi Kasei Pharma Corp-製薬・医療分野：企業M&A・提携分析
    Summary Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The company's portfolio encompasses prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. Its prescr …
  • Singapore Technologies Engineering Ltd (S63)：企業の財務・戦略的SWOT分析
    Singapore Technologies Engineering Ltd (S63) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Pro Petroleum Inc：企業の戦略的SWOT分析
    Pro Petroleum Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Siemens Healthcare GmbH (SHL)：医療機器：M&Aディール及び事業提携情報
    Summary Siemens Healthcare GmbH (Siemens Healthineers), a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT, laboratory diagnostics equipm …
  • Genera Biosystems Ltd (GBI)：製薬・医療：M&Aディール及び事業提携情報
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Magnolia Petroleum Plc：石油・ガス：M&Aディール及び事業提携情報
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆